GlassScriptPhysician profile
Jacquelyn N Rodriguez
NPI 1427264902
$14,551.19
in general payments reported to CMS, 2019-2025
31 companies · $608 in 2025
The $608 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $164 · 2021: $7,437 · 2022: $3,863 · 2023: $998 · 2024: $1,137 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,940.94 | 2021-2025 | |
| Astellas Pharma US INC | $733.31 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $599.21 | 2022-2025 | Novasure, Aptima, Coolseal Generator |
| Abbvie INC. | $573.27 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Novo Nordisk INC | $432.77 | 2019-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $361.72 | 2023-2024 | Myfembree |
| Organon LLC | $262.51 | 2022-2024 | Nexplanon, Nuvaring |
| Smith+Nephew, INC. | $183.43 | 2019-2022 | |
| Aspira Women'S Health INC | $176.74 | 2021-2023 | Ova1 |
| Medtronic, INC. | $139.99 | 2021 | |
| Organogenesis INC. | $129.14 | 2025 | Puraply Wound Matrix |
| Minerva Surgical, INC | $123.50 | 2021 | |
| Baxter Healthcare | $102.10 | 2022 | |
| Daiichi Sankyo INC. | $90.83 | 2020-2022 | |
| Amgen INC. | $81.04 | 2023-2024 | Evenity, Prolia |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $75.11 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $68.32 | 2021-2022 | |
| Exeltis, USA INC. | $57.76 | 2022-2025 | Slynd |
| Currax Pharmaceuticals LLC | $55.74 | 2023-2024 | Contrave |
| Mayne Pharma Commercial LLC | $51.64 | 2025 | |
| Ethicon US, LLC | $45.29 | 2025 | Dermabond, Vistaseal, Harmonic |
| Evofem Biosciences, INC. | $43.00 | 2021-2022 | |
| Lupin INC. | $41.26 | 2019-2020 | |
| Therapeuticsmd, INC. | $40.50 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.68 | 2019-2020 | |
| Coopersurgical, INC. | $24.73 | 2022 | |
| Exact Sciences Corporation | $19.63 | 2024 | Cologuard Collection Kit |
| Gynesonics, INC. | $17.47 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $17.08 | 2024 | Femring, Intrarosa |
| Supernus Pharmaceuticals, INC. | $14.43 | 2025 | Qelbree |
| Lilly USA, LLC | $14.05 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.